Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 535 of 1,261

  1. US 10117871

    3-hydroxypyrimidine-2,4-dione-5-carboxamides as potent inhibitors of HIV

    Regents of the University of Minnesota · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  2. US 10117878

    Ligands for nematode nuclear receptors and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  3. US 10117848

    Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  4. US 10118938

    Arsenoplatin anti-cancer agents

    Northwestern University · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  5. US 10118947

    Modulation of structured polypeptide specificity

    BicycleRD Limited · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  6. US 10117831

    Soft chew pharmaceutical formulations

    First Time US Generics LLC · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  7. US 10118948

    Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  8. US 10118904

    Triazoles for the treatment of Demyelinating Diseases

    Vertex Pharmaceuticals Incorporated · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  9. US 10117945

    mTORC1 inhibitors

    The Regents of the University of California · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  10. US 10117938

    Pharmaceutical formulation

    Semnur Pharmaceuticals, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  11. US 10117907

    Glycosylated PACAP/VIP analogues with enhanced CNS penetration for treatment of neurodegenerative diseases

    Arizona Board of Regents on Behalf of the University of Arizona, a body corporate · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  12. US 10117852

    Glucocorticoid receptor modulators to treat pancreatic cancer

    Corcept Therapeutics Incorporated · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  13. HK 1249412

    PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF

    ALK ABELLO AS · Granted Nov 2, 2018 · Expires Oct 28, 2038

    granted

  14. EP 3394627

    RATIOMETRISCH GEPULSTE CEST-BILDGEBUNG

    BRACCO IMAGING SPA [IT] · Granted Oct 31, 2018 · Expires Oct 26, 2038

    granted

  15. US 10111871

    Nanoparticle drug delivery system and method of treating cancer and neurotrauma

    Northwestern University · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  16. US 10112956

    Heterocyclic compounds having cholesterol 24-hydroxylase activity

    Takeda Pharmaceutical Company Limited · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  17. US 10113151

    Composition of viral vectors in lecithin liposomes, preparation method and treatment methods

    The Regents of the University of California · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  18. US 10111950

    Modified glycolipids and methods of making and using the same

    VACCINEX, INC. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  19. US 10111912

    Herbal formulations

    MONTERO GIDA SANAYI VE TICARET A.S. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  20. US 10111859

    Methods and compositions associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  21. US 10111907

    Methods of treating ischemia

    Fate Therapeutics, Inc. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  22. US 10113170

    Preventing and treating inflammatory skin diseases

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  23. US 10113167

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  24. US 10113145

    Paenibacillus sp. strain, cultivation method and use of the same

    BRIGHT DAIRY & FOOD CO., LTD. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.